Stay updated on Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Dates were added (extending the timeline to 2025–2027) while older dates were removed. This indicates an update to the time-related content without changing core information.
    Difference
    0.3%
    Check dated 2025-10-20T17:10:16.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and a new version tag (v3.2.0), replacing the old v3.1.0; this changes the core content and indicates updated operating status information.
    Difference
    1%
    Check dated 2025-10-06T07:57:41.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes provided.
    Difference
    0.0%
    Check dated 2025-09-29T04:37:43.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the Back to Top element was removed, with no substantive content changes otherwise.
    Difference
    0.1%
    Check dated 2025-09-14T22:23:24.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.
    Difference
    0.1%
    Check dated 2025-09-07T19:39:58.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    The web page has been updated to include new drug information and facility names, while some previous location details and specific drug categories have been removed. Notably, the addition of cancer-related topics and drug names enhances the page's relevance to users seeking information on cancer treatments.
    Difference
    2%
    Check dated 2025-08-31T12:34:18.000Z thumbnail image

Stay in the know with updates to Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.